pCMV6-Entry IL36RN R48W Citations (2)

Originally described in: In Silico and In Vitro Analysis of IL36RN Alterations Reveals Critical Residues for the Function of the Interleukin-36 Receptor Complex.
Hassi NK, Weston T, Rinaldi G, Ng JC, Smahi A, Twelves S, Davan-Wetton C, Fakhreddine D, Fraternali F, Capon F J Invest Dermatol. 2023 Dec;143(12):2468-2475.e6. doi: 10.1016/j.jid.2023.06.191. Epub 2023 Jul 4. PubMed Journal

---

Articles Citing pCMV6-Entry IL36RN R48W

Articles
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation. Aivalioti MM, Bartholdy BA, Pradhan K, Bhagat TD, Zintiridou A, Jeong JJ, Thiruthuvanathan VJ, Pujato M, Paranjpe A, Zhang C, Levine RL, Viny AD, Wickrema A, Verma A, Will B. Blood Cancer Discov. 2022 Sep 6;3(5):444-467. doi: 10.1158/2643-3230.BCD-21-0226. PubMed
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma. Enokido T, Horie M, Yoshino S, Suzuki HI, Matsuki R, Brunnstrom H, Micke P, Nagase T, Saito A, Miyashita N. Mol Cancer Res. 2024 Jan 2;22(1):29-40. doi: 10.1158/1541-7786.MCR-23-0229. PubMed

If you have published an article using this material, please email us at to have your article added to this page.